Murgatroyd L B
Br J Exp Pathol. 1980 Dec;61(6):567-78.
Two experiments were devised to produce an experimental enteropathy. In Experiment I, male Alderley Park rats were dosed daily by gavage with 20 mg/kg and 60 mg/kg of an antibacterial compound ICI 17,363. Animals were killed sequentially at daily intervals up to and including Day 9 to study the development of the enteropathy. In Experiment II rats were dosed daily with 60 mg/kg of the same compound. All animals were killed on Day 5 owing to a rapid development of the enteropathic condition. The duodenum was examined histologically and histochemically. Duodenal changes included vacuolation of columnar epithelial cells and villus stunting. There were marked reductions in mitotic activity in the crypt epithelial cells from Day 7 onwards (Experiment I) and almost total loss of hydrolytic and oxidative enzyme activity. In Experiment II the changes were more severe and haemorrhage and erosion of the duodenal mucosa were observed. The development of the enteropathic lesion appears to be due largely to the antimitotic effect of the compound, although a direct toxic effect upon the intestinal mucosa cannot be ruled out.
设计了两项实验来诱发实验性肠病。在实验I中,给雄性奥尔德利公园大鼠每日经口灌胃20毫克/千克和60毫克/千克的抗菌化合物ICI 17,363。在直至并包括第9天的时间内,每天依次处死动物,以研究肠病的发展情况。在实验II中,给大鼠每日灌胃60毫克/千克的同一化合物。由于肠病状况迅速发展,所有动物在第5天被处死。对十二指肠进行了组织学和组织化学检查。十二指肠的变化包括柱状上皮细胞空泡化和绒毛发育不良。从第7天起(实验I),隐窝上皮细胞的有丝分裂活性显著降低,水解酶和氧化酶活性几乎完全丧失。在实验II中,变化更为严重,观察到十二指肠黏膜出血和糜烂。肠病病变的发展似乎主要归因于该化合物的抗有丝分裂作用,尽管不能排除对肠黏膜的直接毒性作用。